Integrated Microfluidic Device for SARS-CoV-2 Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current SARS-CoV-2 detection methods, such as RT-PCR, are time-consuming, labor-intensive, and require well-trained technicians, while alternative methods like antigen and antibody testing lack specificity and sensitivity, and are not suitable for early-stage detection. Additionally, existing devices for SARS-CoV-2 detection are not fully automated and require manual intervention, lacking both qualitative and quantitative detection capabilities.
Innovation Solution
An integrated microfluidic device comprising a microfluidic chip with LAMP composition, a flow control module, and a temperature control module, which automates the detection process, utilizing primers and RNA capture reagents to perform loop-mediated isothermal amplification and RNA extraction, and includes an optical detection module for fluorescence-based quantification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If RT-PCR is used for SARS-CoV-2 detection, then sensitivity and specificity are improved, but detection time and labor requirements increase
Solution Approach 1:
The patent replaces the complex thermal cycling mechanical system of RT-PCR with an isothermal amplification system using LAMP (loop-mediated isothermal amplification) and RPA (recombinase polymerase amplification) reactions that proceed at constant temperatures (65°C for LAMP, 37°C for RPA), eliminating the need for programmable thermal cyclers and reducing detection time to under 30 minutes while maintaining high sensitivity
Solution Approach 2:
The patent changes the temperature parameter from variable (thermal cycling in RT-PCR) to constant (isothermal conditions in LAMP/RPA), enabling simpler device operation and faster detection. The system uses temperature control modules to maintain constant temperatures appropriate for different amplification reactions, reducing complexity while preserving detection accuracy
2Ease of operation
If manual intervention is used in detection devices, then operational flexibility is maintained, but ease of operation and automation decrease
Solution Approach 1:
The patent merges multiple detection functions (nucleic acid extraction, amplification, and detection) into a single integrated microfluidic chip system. The chip contains integrated chambers for sample processing, magnetic bead-based extraction, LAMP/RPA amplification, and fluorescent detection, all controlled by a centralized microcontroller that automates fluid handling and data analysis, eliminating manual intervention while managing complexity through integration
Solution Approach 2:
The system incorporates automated fluid handling using magnetic actuation to drive reagent and sample flow through the microfluidic channels without manual pumping. Magnetic beads perform self-directed separation and concentration functions, and the microcontroller automatically analyzes fluorescent signals and generates diagnostic results, enabling the system to serve itself with minimal human input
3Productivity
If antibody testing is used for SARS-CoV-2 detection, then simplicity and speed are improved, but sensitivity and early-stage detection capability deteriorate
Solution Approach 1:
The patent performs nucleic acid amplification (LAMP/RPA) before detection, creating a large number of copies of viral genetic material from minimal starting material. This preliminary amplification step enables highly sensitive detection of early-stage infections where viral load is low, while the subsequent fluorescent detection maintains rapid results within 30 minutes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device enables rapid, automated, and sensitive detection of SARS-CoV-2 with high specificity, capable of both qualitative and quantitative analysis, suitable for early-stage detection and operated by ordinary personnel, reducing the need for extensive training and manual intervention.
Implementation Method 1
the chambers comprise a plurality of first functional chambers containing a loop-mediated isothermal amplification (LAMP) composition, and the LAMP composition in each of the first functional chambers comprises primers of SEQ ID NO. 1 to NO. 4
Implementation Method 2
which automates the detection process, utilizing primers and RNA capture reagents to perform loop-mediated isothermal amplification and RNA extraction, and includes an optical detection module for fluorescence-based quantification
Data Source
AI summary
Provided is an integrated microfluidic device for SARS-CoV-2 detection. Also provided is a method for detecting SARS-CoV-2 by using the same, comprising viral lysis, RNA extraction, and reverse-transcription loop-mediated isothermal amplification (RT-LAMP). The integrated microfluidic device of the present disclosure is small in size, automatically operatable, and easy to use by ordinary people, and the present disclosure can achieve rapid detection with high sensitivity and specificity.